Skip to main content

18 October 2026

Last updated: Sunday 18 October 2026

User account anon menu

Login
Register and subscribe

Search

Home
News
About MedNous
Research Directory
Contact Us
- Contact Form

Menu

Breadcrumb

Home
Research Directory

Research Directory

Direct cell reprogramming: Mogrify and Astellas to address hearing loss

Wednesday 14 September 2022

Interviewee/Contributor

Louise Modis

Organisation

Mogrify Ltd

Technology for direct cell reprogramming

Tuesday 10 September 2019

Interviewee/Contributor

Julian Gough

Organisation

Mogrify Ltd

Organisations

Amyl Therapeutics BV
Stanford University School of Medicine
MRC Technology
Alkermes Plc
Ablynx NV
Secarna Pharmaceuticals GmbH
Massachusetts General Hospital
Kiadis Pharma BV
Asgard Therapeutics AB
Cellzome

Interviewees and Contributers

David Hail
J Fraser Wright
David Moller
Frederic Triebel
Richard Holland
Vittore Tamassia and Bruno Paglaria
Janet Lambert
Marie Manley and Zina Chatzidimitriadou
Nigel Davis
Nigel Parker

Select a News Category

Clinical Research
Company News
Finance, Grants, Deals
IPR & Legal
Regenerative Medicine
Regulation & Policy
Research & University News

Recent Appointments

Evotec appoints CSO

Thursday 15 October 2026

New CEO at AL-S Pharma

Wednesday 14 October 2026

Bavarian Nordic appoints new CEO

Monday 12 October 2026

Leadership transition at Nuclera

Monday 12 October 2026

HMNC insider named CEO

Monday 12 October 2026

View more appointments

Looking for more?

MedNous covers medical news and more. See more in our various site sections.

News
Industry appointments
Events
Research directory
Subscribe

Footer

Privacy policy

© 2026 Evernow Publishing Ltd.

Home
News
- News
- Appointments
- Events
About MedNous
Research Directory
Contact Us
- Contact Form